Linvoseltamab In Combination With Carfilzomib Or Bortezomib Shows Promising Initial Results In Earlier Lines Of Treatment For Relapsed/Refractory Multiple Myeloma
RefinitivOkuma süresi: 1 dakikadan kısa
Regeneron Pharmaceuticals Inc 
REGN:
LINVOSELTAMAB IN COMBINATION WITH CARFILZOMIB OR BORTEZOMIB SHOWS PROMISING INITIAL RESULTS IN EARLIER LINES OF TREATMENT FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA
REGENERON PHARMACEUTICALS INC - 90% OBJECTIVE RESPONSE RATE IN LINVOSELTAMAB AND CARFILZOMIB COMBINATION
Bu haberi okumak için giriş yapın veya sonsuza kadar ücretsiz bir hesap oluşturun